The review used data from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS)
A pesar de su potencial, la agencia sanitaria tambin advierte sobre importantes barreras en el acceso mundial a los medicamentos GLP-1
In our opinion, based on our current knowledge, patients should not stop taking semaglutide on this account alone, especially given potential increases in morbidity from conditions that are well controlled by semaglutide, potential adverse effects of hyperglycemia caused by abrupt cessation of treatment, and the seemingly low absolute risk of NAION, the editorial said
This includes checking for contraindications, potential drug interactions, and suitability based on your health profile
Understanding why nausea occurs and how to combat it effectively can help you continue treatment and achieve your weight management goals
This is often less common with liposomal versions